Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
Clinical trial NCT01156077 · COMPLETED
Trial details
- NCT number
- NCT01156077
- Sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-02
- Primary completion
- 2011-09-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.